Most adults with cystic fibrosis (CF) report experiences with painful or frightening medical procedures in childhood after their diagnosis,…
Articles by Patricia Inácio, PhD
Two patients have been dosed in a clinical trial testing BX004, a nebulized phage therapy designed to kill Pseudomonas…
A pediatric gastroenterologist in Missouri has been awarded a $50,000 grant to open a study into the potential…
Problems with the CFTR protein — which causes cystic fibrosis (CF) — limit the replication and spread…
In children with cystic fibrosis (CF) and a first or new-onset Pseudomonas aeruginosa infection, antibiotics given intravenously are not more effective at eliminating…
Elevated levels of DMBT1 in the lungs, a protein previously linked with inflammatory processes, may be a biomarker of progression…
American Airlines and its partners recently raised $1.2 million to support the Cystic Fibrosis Foundation during its 37th annual…
The U.K. Cystic Fibrosis Trust has launched the CFTruths campaign, which is designed to enhance public awareness and understanding of…
Treatment with Trikafta is linked with fewer infection-related hospitalizations and a reduced need for antibiotics among people with…
Worldwide, only 12% of people with cystic fibrosis (CF) have access to the triple combination therapy Trikafta, despite this next-generation…